SCHEMBL29618952

SCHEMBL29618952

c1ccc(-c2cc3cnncc3o2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.50
KDM4E B2RXH2 6/20 0.44
TP53 P04637 5/20 0.44
SMN1; SMN2 Q16637 5/20 0.44
HSD17B10 Q99714 5/20 0.44
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
CYP1A2 P05177 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 3/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CYP1A1 P04798 1/20 0.43
CYP1B1 Q16678 1/20 0.43
CYP19A1 P11511 1/20 0.42
CCR1 P32246 3/20 0.42
CCR5 P51681 3/20 0.42
CCR8 P51685 3/20 0.42
LMNA P02545 2/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29618959 0.89 AHR (0.45) AHRKDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL574760 0.81 GRM4 (0.61) AHRKDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL29478404 0.81 GRM4 (0.61) AHRKDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL5779426 0.73 AHR (0.47) AHRKDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL21295711 0.73 AHR (0.47) AHRKDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL12278511 0.73 AHR (0.53) AHRKDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL12277930 0.73 AHR (0.53) AHRKDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL24776300 0.72 KDM4E (0.54) AHRKDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL12278333 0.72 AHR (0.56) AHRKDM4ETP53SMN1; SMN2HSD17B10
SCHEMBL12278688 0.71 CYP1A2 (0.62) AHRKDM4ETP53SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089377-A1 COMBINATION OF A PD-1 OR PD-L1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER Taizhou Eoc Pharma Co., Ltd. (CN) 2022-05-05 WO disclosed